Meeting of the Advisory Board on Radiation and Worker Health, Subcommittee for Dose Reconstruction Review, National Institute for Occupational Safety and Health, 26153 [2024-07848]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 73 / Monday, April 15, 2024 / Notices
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–07847 Filed 4–12–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Meeting of the Advisory Board on
Radiation and Worker Health,
Subcommittee for Dose
Reconstruction Review, National
Institute for Occupational Safety and
Health
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC) announces the
following meeting for the Subcommittee
for Dose Reconstruction Review of the
Advisory Board on Radiation and
Worker Health (ABRWH or the Advisory
Board). This meeting is open to the
public, but without a public comment
period. The public is welcome to submit
written comments in advance of the
meeting, to the contact person below.
DATES: The meeting will be held on June
4, 2024, from 11 a.m. to 4 p.m., EDT.
Written comments must be received
on or before May 27, 2024.
ADDRESSES: You may submit comments
by mail to: Rashaun Roberts, National
Institute for Occupational Safety and
Health, 1090 Tusculum Avenue, MS C–
24, Cincinnati, Ohio 45226.
Meeting Information: Audio
Conference Call via FTS Conferencing.
The USA toll-free dial-in number is 1–
866–659–0537; the pass code is
9933701.
Written comments received in
advance of the meeting will be included
in the official record of the meeting. The
public is also welcomed to listen to the
meeting by joining the audio conference
(information below). The audio
conference line has 150 ports for callers.
FOR FURTHER INFORMATION CONTACT:
Rashaun Roberts, Ph.D., Designated
Federal Officer, National Institute for
Occupational Safety & Health, Centers
for Disease Control and Prevention,
1090 Tusculum Avenue, Mailstop C–24,
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:44 Apr 12, 2024
Jkt 262001
Cincinnati, Ohio 45226, telephone:
(513) 533–6800, toll free 1(800) 232–
4636, email: ocas@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that
have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule; advice on
methods of dose reconstruction, which
have also been promulgated by HHS as
a final rule; advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program; and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC). In
December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS,
which subsequently delegated this
authority to CDC. NIOSH implements
this responsibility for CDC.
The charter was issued on August 3,
2001, renewed at appropriate intervals,
and rechartered under Executive Order
14109 on March 22, 2024. Unless
continued by the President the Board
will terminate on September 30, 2025,
consistent with E.O. 14109 of September
29, 2023.
Purpose: The Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
(DOE) facility who were exposed to
radiation but for whom it is not feasible
to estimate their radiation dose, and on
whether there is reasonable likelihood
that such radiation doses may have
endangered the health of members of
this class. SDRR is responsible for
overseeing, tracking, and participating
in the reviews of all procedures used in
the dose reconstruction process by the
NIOSH Division of Compensation
Analysis and Support (DCAS) and its
dose reconstruction contractor (Oak
Ridge Associated Universities—ORAU).
Matters to be Considered: The agenda
will include discussions on the
following: 1. Issues Resolution from Set
31. Facilities that may be covered
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
26153
include: Feed Materials Production
Center (FMPC), General Atomics,
General Electric Vallecitos, General
Steel Industries (South Plant), Hanford,
Idaho National Laboratory, Kansas City
Plant, Lawrence Livermore National
Laboratory, Los Alamos National
Laboratory, Metals and Controls Corp.,
Oak Ridge Gaseous Diffusion Plant (K–
25), Oak Ridge National Laboratory (X–
10), Pacific Northwest National
Laboratory, Paducah Gaseous Diffusion
Plant, Pantex Plant, Portsmouth Gaseous
Diffusion Plant, Rocky Flats Plant,
Sandia National Laboratories, Savannah
River Site, and Y–12 Plant; 2. Issues
resolution: Tab 585 from Set 29
(Pantex); 3. Report and further
discussion on changes to selection
criteria. Agenda items are subject to
change as priorities dictate.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–07848 Filed 4–12–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Solicitation of Nominations for
Appointment to the Advisory Council
for the Elimination of Tuberculosis
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC), within the
Department of Health and Human
Services (HHS), is seeking nominations
for membership on the Advisory
Council for the Elimination of
Tuberculosis (ACET). ACET consists of
10 experts including the Chair in fields
associated with public health,
epidemiology, immunology, infectious
diseases, pulmonary disease, pediatrics,
SUMMARY:
E:\FR\FM\15APN1.SGM
15APN1
]]>Agencies
[Federal Register Volume 89, Number 73 (Monday, April 15, 2024)]
[Notices]
[Page 26153]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-07848]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Meeting of the Advisory Board on Radiation and Worker Health,
Subcommittee for Dose Reconstruction Review, National Institute for
Occupational Safety and Health
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC) announces the
following meeting for the Subcommittee for Dose Reconstruction Review
of the Advisory Board on Radiation and Worker Health (ABRWH or the
Advisory Board). This meeting is open to the public, but without a
public comment period. The public is welcome to submit written comments
in advance of the meeting, to the contact person below.
DATES: The meeting will be held on June 4, 2024, from 11 a.m. to 4
p.m., EDT.
Written comments must be received on or before May 27, 2024.
ADDRESSES: You may submit comments by mail to: Rashaun Roberts,
National Institute for Occupational Safety and Health, 1090 Tusculum
Avenue, MS C-24, Cincinnati, Ohio 45226.
Meeting Information: Audio Conference Call via FTS Conferencing.
The USA toll-free dial-in number is 1-866-659-0537; the pass code is
9933701.
Written comments received in advance of the meeting will be
included in the official record of the meeting. The public is also
welcomed to listen to the meeting by joining the audio conference
(information below). The audio conference line has 150 ports for
callers.
FOR FURTHER INFORMATION CONTACT: Rashaun Roberts, Ph.D., Designated
Federal Officer, National Institute for Occupational Safety & Health,
Centers for Disease Control and Prevention, 1090 Tusculum Avenue,
Mailstop C-24, Cincinnati, Ohio 45226, telephone: (513) 533-6800, toll
free 1(800) 232-4636, email: [email protected].
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing advice
on the development of probability of causation guidelines that have
been promulgated by the Department of Health and Human Services (HHS)
as a final rule; advice on methods of dose reconstruction, which have
also been promulgated by HHS as a final rule; advice on the scientific
validity and quality of dose estimation and reconstruction efforts
being performed for purposes of the compensation program; and advice on
petitions to add classes of workers to the Special Exposure Cohort
(SEC). In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC. NIOSH implements this
responsibility for CDC.
The charter was issued on August 3, 2001, renewed at appropriate
intervals, and rechartered under Executive Order 14109 on March 22,
2024. Unless continued by the President the Board will terminate on
September 30, 2025, consistent with E.O. 14109 of September 29, 2023.
Purpose: The Advisory Board is charged with (a) providing advice to
the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and (c) upon request by the (DOE) facility
who were exposed to radiation but for whom it is not feasible to
estimate their radiation dose, and on whether there is reasonable
likelihood that such radiation doses may have endangered the health of
members of this class. SDRR is responsible for overseeing, tracking,
and participating in the reviews of all procedures used in the dose
reconstruction process by the NIOSH Division of Compensation Analysis
and Support (DCAS) and its dose reconstruction contractor (Oak Ridge
Associated Universities--ORAU).
Matters to be Considered: The agenda will include discussions on
the following: 1. Issues Resolution from Set 31. Facilities that may be
covered include: Feed Materials Production Center (FMPC), General
Atomics, General Electric Vallecitos, General Steel Industries (South
Plant), Hanford, Idaho National Laboratory, Kansas City Plant, Lawrence
Livermore National Laboratory, Los Alamos National Laboratory, Metals
and Controls Corp., Oak Ridge Gaseous Diffusion Plant (K-25), Oak Ridge
National Laboratory (X-10), Pacific Northwest National Laboratory,
Paducah Gaseous Diffusion Plant, Pantex Plant, Portsmouth Gaseous
Diffusion Plant, Rocky Flats Plant, Sandia National Laboratories,
Savannah River Site, and Y-12 Plant; 2. Issues resolution: Tab 585 from
Set 29 (Pantex); 3. Report and further discussion on changes to
selection criteria. Agenda items are subject to change as priorities
dictate.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-07848 Filed 4-12-24; 8:45 am]
BILLING CODE 4163-18-P
